Should women with a BRCA1/2 mutation aged 60 and older be offered intensified breast cancer screening? – A cost-effectiveness analysis
1995 ◽
Vol 4
(1)
◽
pp. 49-57
2016 ◽
Vol 17
(2)
◽
pp. 609-614
◽
2021 ◽
pp. cebp.1230.2020
1997 ◽
Vol 6
(2)
◽
pp. 145-151
◽
2008 ◽
Vol 100
(18)
◽
pp. 1290-1300
◽